Assessing Sexual Dysfunction, Part 1: Male Sexual Dysfunction
Seth D. Cohen
Search for other papers by Seth D. Cohen in
Current site
Google Scholar
PubMed
Close
,
Steven Mandel
Search for other papers by Steven Mandel in
Current site
Google Scholar
PubMed
Close
, and
David B. Samadi
Search for other papers by David B. Samadi in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract

To properly assess men and women with sexual dysfunction, evaluators should take a biopsychosocial approach that may require consultation with multiple health care professionals from various fields in order to get to the root of the sexual dysfunction; this multidisciplinary methodology offers the best chance of successful treatment. For males, this article focuses on erectile dysfunction (ED) and hypogonadism. The initial evaluation of ED involves a thorough case history, preferably taken from the patient and partner, physical examination, and proper laboratory and diagnostic tests, including an acknowledgment of the subjective complaint. The diagnosis is established on the basis of an individual's report of the consistent inability to attain and maintain an erection sufficient to permit satisfactory sexual intercourse. Initial workups for ED should entail a detailed history that can be obtained from a validated questionnaire such as the International Index of Erectile Function and the Sexual Health Inventory for Men. Hypogonadism is evaluated using the validated Androgen Deficiency in the Aging Male questionnaire and laboratory testing for testosterone deficiency. Treatments logically can begin with the least invasive and then progress to more invasive strategies after appropriate counseling. The last and most important treatment component when caring for men with sexual dysfunction—and, arguably, the least practiced—is close follow-up.

  • 1.

    Aboseif SR, Wetterauer U, Breza J, et al.The effect of venous incompetence and arterial insufficiency on erectile function: an animal model. J Urol. 1990;144:790793.

    • Search Google Scholar
    • Export Citation
  • 2.

    Barnett ZL, Robleda-Gomez S, Pachana NA. Viagra: the little blue pill with big repercussions. Aging Ment Health. 2012;16:8488.

  • 3.

    Bennett AH, Carpenter AJ, Barada JH. An improved vasoactive drug combination for a pharmacological erection program. J Urol. 1991;146:15641565.

    • Search Google Scholar
    • Export Citation
  • 4.

    Bernstein AN, Levinson AW, Hobbs AR, Lavery HJ, Samadi DB. Validation of online administration of the sexual health inventory for men. J Urol. 2013;189:14561461.

    • Search Google Scholar
    • Export Citation
  • 5.

    Broderick GA, Arger P. Duplex Doppler ultrasonography: noninvasive assessment of penile anatomy and function. Semin Roentgenol. 1993;28:4356.

    • Search Google Scholar
    • Export Citation
  • 6.

    Cheitlin MD, Hutter AM Jr, Brindis RG, et al.ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol. 1999;33:273282.

    • Search Google Scholar
    • Export Citation
  • 7.

    Cilurzo P, Canale D, Turchi P, Giorgi PM, Menchini Fabris GF. The RigiScan system in the diagnosis of male sexual impotence. Arch Ital Urol Androl. 1992;64(suppl. 2):8185.

    • Search Google Scholar
    • Export Citation
  • 8.

    Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol. 2002;53:545574.

    • Search Google Scholar
    • Export Citation
  • 9.

    Dicks B, Bastuba M, Goldstein I. Penile revascularization—contemporary update. Asian J Androl. 2013;151:59.

  • 10.

    Dorsey P, Keel C, Klavens M, Helstrom WJ. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother. 2010;11: 11091122.

    • Search Google Scholar
    • Export Citation
  • 11.

    Fallon B. Intracavernous injection therapy for male erectile dysfunction. Urol Clin North Am. 1995;22:833845.

  • 12.

    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay J B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urology. 1994;151:5461.

    • Search Google Scholar
    • Export Citation
  • 13.

    Floth A, Schramek P. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone. J Urol. 1991;145:5659.

    • Search Google Scholar
    • Export Citation
  • 14.

    Helgason AR, Arver S, Adolfson I, Dickman P, Granath F, Steineck G. “Potency”: the validation of information from a self-administered questionnaire using objective measurements of night-time erections and test-retest reliability. Br J Urol. 1998;81:135141.

    • Search Google Scholar
    • Export Citation
  • 15.

    Karacan I, Scott FB, Salis PJ, et al.Nocturnal erections, differential diagnosis of impotence, and diabetes. Biol Psychiatry. 1977. Jun;12(3):37380.

    • Search Google Scholar
    • Export Citation
  • 16.

    Karacan I, Williams RL, Thornby JI, Salis PJ. Sleep related penile tumescence as a function of age. Am J Psychiatry. 1975;132:932937.

    • Search Google Scholar
    • Export Citation
  • 17.

    Kessler WO. Nocturnal penile tumescence. Urol Clin North Am. 1988 Feb;15(1):8186.

  • 18.

    Motiwala HG, Patel DD, Joshi SP, Baxi HM, Desai KD, Shah KN. Experience with penile venous surgery. Urol Int. 1993;51:914.

  • 19.

    Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang J-H. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey. J Sex Med. 22007;4:5765.

    • Search Google Scholar
    • Export Citation
  • 20.

    Levine AL, Lenting L. Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Urol Clin North Am. 1995;22:775788.

    • Search Google Scholar
    • Export Citation
  • 21.

    Licht MR, Lewis RW, Wollan PC, Harris CD. Comparison of RigiScan and sleep laboratory nocturnal penile tumescence in the diagnosis of organic impotence. J Urol. 1995;154:17401743.

    • Search Google Scholar
    • Export Citation
  • 22.

    Linet OI, Neff LL. Intracavernous prostaglandin E1 in erectile dysfunction. Clin Investig. 1994;72:139149.

  • 23.

    Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med. 1996;334:873877.

    • Search Google Scholar
    • Export Citation
  • 24.

    Lue TF, Hricak H, Marich KW, Tanagho EA. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155:777781.

    • Search Google Scholar
    • Export Citation
  • 25.

    Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829836.

  • 26.

    Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al.Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49:12391242

    • Search Google Scholar
    • Export Citation
  • 27.

    Ninan PT. The functional anatomy, neurochemistry, and pharmacology of anxiety. J Clin Psychiatry. 1999;60(suppl 22):1217.

  • 28.

    Nutt DJ, Glue P, Lawson C. The neurochemistry of anxiety: an update. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:737752.

  • 29.

    Palmer MJ, Bell AS, Fox DN, Brown DG. Design of second generation phosphodiesterase 5 inhibitors. Curr Top Med Chem. 2007;7:405419.

  • 30.

    Porst H, Giuliano F, Glina S, et al.Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol. 2006;50:351359.

    • Search Google Scholar
    • Export Citation
  • 31.

    Puyau FA, Lewis RW. Corpus cavernosography. Pressure flow and radiography. Invest Radiol. 1983;18:517522.

  • 32.

    Rajkumar RP. The impact of disrupted childhood attachment on the presentation of psychogenic erectile dysfunction: an exploratory study. J Sex Med. 2015 Mar;12(3):798803

    • Search Google Scholar
    • Export Citation
  • 33.

    Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319326.

    • Search Google Scholar
    • Export Citation
  • 34.

    Rosen R, Riley A, Wagner G, et al.The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49:822830.

    • Search Google Scholar
    • Export Citation
  • 35.

    Rudnick J, Bödecker R, Weidner W. Significance of the intracavernosal pharmacological injection test, pharmacocavernosography, artificial erection and cavernosometry in the diagnosis of venous leakage. Urol Int. 1991;46:338343.

    • Search Google Scholar
    • Export Citation
  • 36.

    Shabsigh R, Fishman IJ, Toombs BD, Skolkin M. Venous leaks: anatomical and physiological observations. J Urol. 1991;146:12601265.

  • 37.

    Sachs BD. The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction. Int J Impot Res. 2003;15:7278.

    • Search Google Scholar
    • Export Citation
  • 38.

    Shamloul R, Ghanem H. Erectile dysfunction. The Lancet. 2013;381:153165.

  • 39.

    Sugimori H, Yoshida K, Tanaka T, et al.Relationships between erectile dysfunction, depression, and anxiety in Japanese subjects. J Sex Med. 2005 May;2(3):390396.

    • Search Google Scholar
    • Export Citation
  • 40.

    Udelson D, Park K, Sadeghi-Nejad H, Salimpour P, Krane RJ, Goldstein I. Axial penile buckling forces vs Rigiscan radial rigidity as a function of intracavernosal pressure: why Rigiscan does not predict functional erections in individual patients. Int J Impot Res. 1999 Dec;11(6):327337

    • Search Google Scholar
    • Export Citation
  • 41.

    van Ahlen H, Peskar BA, Sticht G, Hertfelder HJ. Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol. 1994;151:12271230.

    • Search Google Scholar
    • Export Citation
  • 42.

    Wasserman MD, Pollak CP, Spielman AJ, Weitzman ED. The differential diagnosis of impotence. The measurement of nocturnal penile tumescence. JAMA. 1980; 24320:20382042.

    • Search Google Scholar
    • Export Citation
  • 43.

    Yang Y, Hu JL, Ma Y, et al.Pharmaco-induced erections for penile color-duplex ultrasound: oral PDE5 inhibitors or intracavernosal injection? Int J Impot Res. 2012;245:191195.

    • Search Google Scholar
    • Export Citation
  • 44.

    Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782787.

  • 45.

    Zorgniotti AW, Lefleur RS. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol. 1985;133:3941.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 36 36 36
Full Text Views 27 27 27
PDF Downloads 0 0 0
Save